Technical analyst Mehul Kothari of Anand Rathi has flagged potential reversal setups in Tata Steel, Max Healthcare, and Narayana Hrudayalaya for August 26, 2026. While technical charts suggest these stocks are testing support levels, investors should also weigh these patterns against company-specific risks, including legal challenges for Tata Steel and margin pressures in the healthcare sector.
Technical analysts at Anand Rathi have identified three stocks—Tata Steel, Max Healthcare Institute, and Narayana Hrudayalaya—that are showing potential for a trend reversal based on current trading patterns. While technical indicators like price support levels and trend divergence are being used to map these entries, it is important for investors to consider both the technical setup and the underlying business context.
Tata Steel Technical Levels and Legal Context
For Tata Steel, the analyst noted a pattern of repeated buying interest between the ₹180 and ₹185 range. The technical recommendation suggests observing the stock in the ₹184 to ₹188 range, viewing it as an accumulation zone where the price might rebound. However, beyond the charts, the company is dealing with a significant legal matter involving a ₹1,755 crore mining demand notice. While the Ministry of Coal's Revisional Authority has granted interim relief by directing that no coercive steps be taken while the case is pending, this legal situation remains a material factor for long-term investors to watch alongside the daily price action.
Healthcare Sector Dynamics
In the healthcare space, Max Healthcare Institute is being monitored as a potential reversal candidate in the ₹1,000 to ₹1,020 zone. The analysis points to technical structures, such as Fibonacci retracement levels, which often precede trend changes. While the chart setup appears constructive, the company has been focused on capital-intensive plans like increasing bed capacity and medical education, which could impact short-term financial flexibility. Investors tracking this stock should also watch for any impact on margins, a common pressure point for hospital chains facing changes in government health scheme pricing.
Narayana Hrudayalaya is also seeing technical interest, with the ₹1,830 to ₹1,860 range flagged as a possible support area following a recent retracement. This positive technical view aligns with some market sentiment, including a recent target price upgrade by Kotak Securities to ₹2,350. As with any healthcare stock, performance remains tied to patient volume growth and the ability to maintain profitability amid rising operational costs.
Risks and Monitorables
It is important to remember that technical recommendations are short-term in nature. These setups rely on specific support levels, such as the ₹178 stop-loss for Tata Steel and ₹980 for Max Healthcare. If the share price falls below these key support zones, the technical thesis may be invalidated. Investors should treat these price levels as monitors rather than certainties, as broader market volatility or sector-specific news can quickly change the direction of these stocks regardless of the technical chart patterns.